cbdMD reported preliminary financial results for the fourth quarter of fiscal 2025 and the year ended September 30, 2025.
Net sales revenue for fiscal 2025 is expected to range between $19.1 and $19.3 million compared to $19.5 million in fiscal 2024.
The net loss for fiscal 2025 is expected to improve from $3.7 million to a range of between $1.9 and $2.1 million.
Net Sales Expectations
Fiscal 2025 net sales range: $19.1-$19.3 million; Q4 2025 net sales range: $4.7-$4.9 million.
Profitability Improvement
Expected net loss improvement in fiscal 2025 from $3.7 million to $1.9-$2.1 million.
Strategy Success
Positive sequential and year-over-year revenue growth in Q4 2025.
- cbdMD has reported mostly stable net sales in fiscal 2025 compared to the previous year. The net loss is expected to show significant improvement, indicating a positive outlook for profitability.
- The company's strategy of strengthening the business has resulted in positive revenue growth in the fourth quarter of fiscal 2025, showcasing the effectiveness of their operating model and growth initiatives.
cbdMD's optimistic financial outlook for fiscal 2025, with expected revenue stability and improved net loss, reflects the success of their strategic initiatives and disciplined cost management. The positive year-over-year revenue growth in Q4 2025 indicates a strong foundation for future growth and earnings improvement.